×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

ZyVersa Therapeutics Inc. (ZVSA) NASDAQ

$4.83 (0.22) (-4.36%)

Market Cap: $4.22M

As of 06/20/24 04:00 PM EDT. Market closed.

(ZVSA)

ZyVersa Therapeutics Inc. (ZVSA)
NASDAQ

$4.83
(0.22) (-4.36%)

Market Cap: $4.22M

As of 06/20/24 04:00 PM EDT. Market closed.

Add to Portfolio

variant pharmaceuticals is an orphan drug company leveraging advanced proprietary technologies to develop best-in-class drugs for patients with rare diseases. our accomplished leadership team, each with more than 15 years of demonstrated success in the biopharmaceutical and medical industries, focuses on assuring that our development efforts serve the needs of all our stakeholders: patients, ... read more

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Full Time Employees
12
URL
Address
.
PRICE CHART FOR ZYVERSA THERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$5.05
Days Range
$4.81 - $5.29
52 week range
$3.94 - $115.15
Volume
21,816
Avg. Volume (30 days)
79,582
Market Cap
$4.22M
Dividend Yield
-
P/E
-
Shares Outstanding
834,896
Open
-
Previous Close
$5.05
Days Range
$4.81 - $5.29
52 week range
$3.94 - $115.15
Volume
21,816
Avg. Volume (30 days)
79,582
Market Cap
$4.22M
Dividend Yield
-
P/E
-
Shares Outstanding
834,896
FINANCIAL STATEMENTS FOR ZYVERSA THERAPEUTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR ZYVERSA THERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Wolfe PeterChief Financial OfficerDec 16, 2022 Option Exercise$2.883,0008,64544,585Dec 20, 2022, 04:00 PM
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Wolfe PeterChief Financial Officer12/16/20228,645
CHANGE IN SHARES OUTSTANDING FOR ZYVERSA THERAPEUTICS INC
STOCK BUYBACKS FOR ZYVERSA THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
03/31/2024
06/30/2023
22.23%
3Q
03/31/2024
09/30/2022
-9.69%
6Q
03/31/2024
06/30/2022
-9.69%
7Q
03/31/2024
12/31/2021
-9.69%
9Q
03/31/2024
09/30/2021
-9.69%
10Q
Load More

Period of Report: 03/31/2024

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2023
22.23%
3Q
09/30/2022
-9.69%
6Q
06/30/2022
-9.69%
7Q
12/31/2021
-9.69%
9Q
09/30/2021
-9.69%
10Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR ZYVERSA THERAPEUTICS INC
LOADING...